SIGN UP
LOG IN
MARKET
ERNA
ERNA
Eterna Therapeutics Inc
NASDAQ
1.450
-0.050
-3.33%
After Hours: 1.400 -0.05 -3.45% 17:17 12/07 EST
OPEN
1.416
PREV CLOSE
1.500
HIGH
1.500
LOW
1.350
VOLUME
44.52K
TURNOVER
0
52 WEEK HIGH
6.33
52 WEEK LOW
0.8401
MARKET CAP
7.84M
P/E (TTM)
-0.3471
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers dare bioscience (nasdaq:dare) shares rose 31.1% to $0.46 during thursday's pre-market session. Anixa biosciences shares moved upwards by 20.35%. Cerevel therapeutics hldg shares rose 14.54%. Vanda pharma stock rose 20.04%.
Benzinga · 14h ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers reshape lifesciences stock moved upwards by 17.9% to $0.31 during wednesday's after-market session. Cerevel therapeutics hldg (nasdaq:cere) stock rose 13.99% and monopar therapeutic shares rose by 15.5%. Losers wave life sciences stock declined by 18.4% and maxcyte stock fell by 11.12%.
Benzinga · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Hawaiian holdings (nasdaq:ha) stock is rocketing more than 174% after announcing a merger plan with alaska air. Wisa technologies shares are soaring over 162% after signing a five-year license agreement. Hawaiian holdings is one of the biggest pre-market stock movers for monday morning.
Investorplace · 3d ago
Weekly Report: what happened at ERNA last week (1127-1201)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Lucy scientific discovery shares increased by 46.4% to $0.3 during friday's after-market session. Lexeo therapeutics stock rose 23.53% and neximmune shares moved upwards by 20.0%. Conduit pharmaceuticals stock increased by 6.04% and telesis bio shares fell 15.4%.
Benzinga · 6d ago
Weekly Report: what happened at ERNA last week (1120-1124)?
Weekly Report · 11/27 10:30
Weekly Report: what happened at ERNA last week (1113-1117)?
Weekly Report · 11/20 10:28
Eterna Therapeutics Inc: Current report
Press release · 11/16 23:35
About ERNA
Eterna Therapeutics Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on developing advanced therapies using messenger ribonucleic acid (RNA) (mRNA) cell engineering technology. The Company has a portfolio of over 100 patents covering mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system, which the Company collectively refers to as its mRNA technology platform. Its mRNA gene-editing technology is designed to delete, insert, and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to fight cancer.
Webull offers Eterna Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.